BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25171765)

  • 1. Analytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers.
    Boja ES; Fehniger TE; Baker MS; Marko-Varga G; Rodriguez H
    J Proteome Res; 2014 Dec; 13(12):5325-32. PubMed ID: 25171765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in mass spectrometry proteomics for biomedical research.
    Li X; Wang W; Chen J
    Sci China Life Sci; 2017 Oct; 60(10):1093-1113. PubMed ID: 29039124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four areas of engagement requiring strengthening in modern proteomics today.
    Fehniger TE; Boja ES; Rodriguez H; Baker MS; Marko-Varga G
    J Proteome Res; 2014 Dec; 13(12):5310-8. PubMed ID: 25405748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optomechanical devices for deep plasma cancer proteomics.
    Kosaka PM; Calleja M; Tamayo J
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):26-38. PubMed ID: 28867489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perseus: A Bioinformatics Platform for Integrative Analysis of Proteomics Data in Cancer Research.
    Tyanova S; Cox J
    Methods Mol Biol; 2018; 1711():133-148. PubMed ID: 29344888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives.
    Hernandez-Valladares M; Bruserud Ø; Selheim F
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
    Findeisen P; Neumaier M
    Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.
    Manes NP; Nita-Lazar A
    J Proteomics; 2018 Oct; 189():75-90. PubMed ID: 29452276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational biomarker pipeline from discovery to clinical implementation: plasma proteomic biomarkers for cardiac transplantation.
    Cohen Freue GV; Meredith A; Smith D; Bergman A; Sasaki M; Lam KK; Hollander Z; Opushneva N; Takhar M; Lin D; Wilson-McManus J; Balshaw R; Keown PA; Borchers CH; McManus B; Ng RT; McMaster WR;
    PLoS Comput Biol; 2013 Apr; 9(4):e1002963. PubMed ID: 23592955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry-based biomarker discovery: toward a global proteome index of individuality.
    Hawkridge AM; Muddiman DC
    Annu Rev Anal Chem (Palo Alto Calif); 2009; 2():265-77. PubMed ID: 20636062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative proteomic approaches for cancer biomarker discovery.
    Faca V; Krasnoselsky A; Hanash S
    Biotechniques; 2007 Sep; 43(3):279, 281-3, 285. PubMed ID: 17907570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted mass spectrometry approaches for protein biomarker verification.
    Meng Z; Veenstra TD
    J Proteomics; 2011 Nov; 74(12):2650-9. PubMed ID: 21540133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The path to clinical proteomics research: integration of proteomics, genomics, clinical laboratory and regulatory science.
    Boja ES; Rodriguez H
    Korean J Lab Med; 2011 Apr; 31(2):61-71. PubMed ID: 21474978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics approaches in the quest of kidney disease biomarkers.
    Frantzi M; Bitsika V; Charonis A; Vlahou A
    Prilozi; 2011; 32(2):33-51. PubMed ID: 22286613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach.
    Percy AJ; Yang J; Chambers AG; Mohammed Y; Miliotis T; Borchers CH
    Adv Exp Med Biol; 2016; 919():515-530. PubMed ID: 27975233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker discovery in mass spectrometry-based urinary proteomics.
    Thomas S; Hao L; Ricke WA; Li L
    Proteomics Clin Appl; 2016 Apr; 10(4):358-70. PubMed ID: 26703953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current affairs in quantitative targeted proteomics: multiple reaction monitoring-mass spectrometry.
    Yocum AK; Chinnaiyan AM
    Brief Funct Genomic Proteomic; 2009 Mar; 8(2):145-57. PubMed ID: 19279071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer proteomics.
    Tan HT; Lee YH; Chung MC
    Mass Spectrom Rev; 2012; 31(5):583-605. PubMed ID: 22422534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics and islet research.
    Ahmed M
    Adv Exp Med Biol; 2010; 654():363-90. PubMed ID: 20217506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.